Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-079126
Filing Date
2023-07-07
Accepted
2023-07-07 16:15:11
Documents
1
Group Members
COSTAS CONSTANTINIDESIAN CHAROUBNEXTECH CROSSOVER I SCSPROCCO SGOBBO

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2320787d1_sc13g.htm SC 13G 108123
  Complete submission text file 0001104659-23-079126.txt   109763
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Subject) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91490 | Film No.: 231076942
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 RUE LOU HEMMER SENNINGERBERG N4 L-1748
Business Address 8 RUE LOU HEMMER SENNINGERBERG N4 L-1748 41.443666611
Nextech Crossover I GP S.a r.l. (Filed by) CIK: 0001916761 (see all company filings)

EIN.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G